Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: MisterED who wrote (3946)	12/20/1997 1:28:00 PM
From: EyeDrMike	Respond to of 23519

it was specifically answered in the conference call that production of normal volume, 800,000 units a month, was expected by mid-Jan 98. mike

To: MisterED who wrote (3946)	12/20/1997 2:34:00 PM
From: sailor	Respond to of 23519

MisterED The new plant can produce all they want, they just can't ship until they get FDA approval. Sailor

To: MisterED who wrote (3946)	12/20/1997 3:30:00 PM
From: MisterED	Read Replies (1) \| Respond to of 23519

I just got my Saturday copy of Barron's and looked in the index for Vivus. Nothing. I looked under Pfizer, and the index refered to page 14. What do I find? Two columns about Vivus and a graph of Vivus' price action since January. How does Pfizer do it? I will be loking forward to the thread's comments about the article. It is definetely twisting the truth as usual, and talks nothing about the fact that Vivus had to curtail their advertising and promotion due to limited production capabilities. There is nothing new IMHO.